文献速递血管炎

大血管炎中患者、医生、影像与实验室评估指标之间的关系

Outcome Measures in Large Vessel Vasculitis: Relationship Between Patient-, Physician-, Imaging-, and Laboratory-Based Assessments.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2020-01-01

该前瞻性观察队列纳入112例大血管炎患者(GCA与TAK各56例),共296次访视。相关性网络分析显示各类评估指标按类型独立聚类,医生整体评估与所有其他类型关联但相关性中等;患者报告结局与PETVAS不相关,仅PtGA与CRP弱相关。结论支持需开发复合结局指标或标准化多维度评估集。

要点

  • 大血管炎各评估维度独立聚类,医生整体评估居中关联但相关性仅为中等。
  • 患者报告结局之间强相关,但与PETVAS不相关,仅PtGA与CRP弱相关。
  • 临床评估由活动转为缓解时ESR、CRP和PETVAS显著下降。

核心结论

  • 大血管炎的疾病评估指标由相互独立但互补的结局构成,支持需开发复合结局指标或覆盖多类结局的标准化评估集。

研究设计与样本

  • 前瞻性观察队列纳入112例大血管炎患者(GCA 56例、TAK 56例),共296次访视,中位随访6个月。
  • 独立记录患者报告结局、医生整体评估、实验室指标(CRP、ESR)及影像学指标(PETVAS)。

主要发现

  • 相关性网络分析显示各评估指标按结局类型独立聚类。
  • PhGA与所有其他结局类型居中关联,但相关性中等(ρ=0.12-0.32;P<0.05)。
  • PETVAS、CRP水平和PtGA与临床活动性疾病独立相关。
  • 4项患者报告结局之间强相关(ρ=0.35-0.60;P<0.0001)。
  • 患者报告结局与PETVAS不相关,仅PtGA与CRP相关(ρ=0.16;P<0.01)。

关键数值与推荐

  • 临床评估由活动转为缓解的患者(n=29)在缓解访视时ESR、CRP和PETVAS显著下降。
  • 临床评估由缓解转为活动的患者(n=11)在活动访视时CRP和PtGA显著升高。

临床怎么用

  • 临床评估大血管炎活动度时应综合患者报告、医生评估、实验室和影像多维度信息,不宜依赖单一指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the relationship between measures of disease assessment in patients with large vessel vasculitis. METHODS: Patients with giant cell arteritis (GCA) or Takayasu arteritis (TAK) were recruited into a prospective, observational cohort. Assessments within the following outcomes were independently recorded: 1) patient-reported outcomes (Multidimensional Fatigue Inventory, patient global assessment of disease activity [PtGA], Short Form 36 health survey [SF-36], Brief Illness Perception Questionnaire), 2) physician global assessment of disease activity (PhGA), 3) laboratory outcomes (C-reactive protein [CRP] level, erythrocyte sedimentation rate [ESR]), and 4) imaging outcomes (PETVAS, a qualitative score of vascular 18 F-fluorodeoxyglucose-positron emission tomography activity). RESULTS: Analyses were performed on 112 patients (GCA = 56, TAK = 56), over 296 visits, with a median follow-up of 6 months. Correlation network analysis revealed assessment measures clustered independently by type of outcome. PhGA was centrally linked to all other outcome types, but correlations were modest (ρ = 0.12-0.32; P < 0.05). PETVAS, CRP level, and PtGA were independently associated with clinically active disease. All 4 patient-reported outcomes strongly correlated with each other (ρ = 0.35-0.60; P < 0.0001). Patient-reported outcomes were not correlated with PETVAS, and only PtGA correlated with CRP level (ρ = 0.16; P < 0.01). Patients whose clinical assessment changed from active disease to remission (n = 29) had a corresponding significant decrease in ESR, CRP level, and PETVAS at the remission visit. Patients whose clinical assessment changed from remission to active disease (n = 11) had a corresponding significant increase in CRP level and PtGA at the active visit. CONCLUSION: Measures of disease assessment in large vessel vasculitis consist of independent, yet complementary, outcomes, supporting the need to develop composite outcome measures or a standard set of measures covering multiple types of outcomes.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Rimland CA, Quinn KA, Rosenblum JS, et al. Outcome Measures in Large Vessel Vasculitis: Relationship Between Patient-, Physician-, Imaging-, and Laboratory-Based Assessments. Arthritis Care Res (Hoboken). 2020. PMID: 31785185. doi:10.1002/acr.24117

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。